Ulla Kring Hansen
Overview
Explore the profile of Ulla Kring Hansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borch A, Carri I, Reynisson B, Garcia Alvarez H, Munk K, Montemurro A, et al.
Front Immunol
. 2024 Apr;
15:1360281.
PMID: 38633261
Background: Mutation-derived neoantigens are critical targets for tumor rejection in cancer immunotherapy, and better tools for neoepitope identification and prediction are needed to improve neoepitope targeting strategies. Computational tools have...
2.
Hansen U, Church C, Carnaz Simoes A, Frej M, Bentzen A, Tvingsholm S, et al.
J Clin Invest
. 2024 Apr;
134(8).
PMID: 38618958
Merkel cell carcinoma (MCC) is a highly immunogenic skin cancer primarily induced by Merkel cell polyomavirus, which is driven by the expression of the oncogenic T antigens (T-Ags). Blockade of...
3.
Kristensen N, Dionisio E, Bentzen A, Tamhane T, Kemming J, Nos G, et al.
Sci Adv
. 2024 Apr;
10(15):eadm8951.
PMID: 38608022
CD8 T cells provide immunity to virus infection through recognition of epitopes presented by peptide major histocompatibility complexes (pMHCs). To establish a concise panel of widely recognized T cell epitopes...
4.
Tvingsholm S, Frej M, Rafa V, Hansen U, Ormhoj M, Tyron A, et al.
J Immunother Cancer
. 2023 Aug;
11(8).
PMID: 37586765
Background: Adoptive cell therapy (ACT) has shown promising results for the treatment of cancer and viral infections. Successful ACT relies on ex vivo expansion of large numbers of desired T-cells...
5.
Hansen U, Lyngaa R, Ibrani D, Church C, Verhaegen M, Dlugosz A, et al.
J Invest Dermatol
. 2021 Jul;
142(1):239-243.e13.
PMID: 34298058
No abstract available.
6.
Hansen U, Ramskov S, Bjerregaard A, Borch A, Andersen R, Draghi A, et al.
Front Immunol
. 2020 Apr;
11:373.
PMID: 32226429
Mutation-derived neoantigens are important targets for T cell-mediated reactivity toward tumors and, due to their unique tumor expression, an attractive target for immunotherapy. Neoepitope-specific T cells have been detected across...
7.
Becker J, Stang A, Zur Hausen A, Fischer N, DeCaprio J, Tothill R, et al.
Cancer Immunol Immunother
. 2017 Dec;
67(3):341-351.
PMID: 29188306
Merkel cell carcinoma (MCC) is a highly aggressive, often lethal neuroendocrine cancer. Its carcinogenesis may be either caused by the clonal integration of the Merkel cell polyomavirus into the host...